Isibloom Kit
Product Images NDC 70700-113

5 FDA label images from Xiromed, Llc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Isibloom (NDC 70700-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 2

Fig 2
A forest plot chart comparing effect estimates (odds ratios or relative risks) from various women's health studies between 2002 and 2017. The horizontal axis is labeled 'Effect Estimate (OR/RR)' ranging from -1.5 to 2. Each study is listed on the left, with corresponding effect estimate points and confidence intervals displayed as horizontal lines and dots, showing a range of effect sizes mainly centered around 1.0.*
FDA Label Image

Structure (Image 01)

Structure (Image 01)
Chemical structure diagrams of desogestrel and ethinyl estradiol, the active ingredients in Isibloom. The image shows molecular structures with labeled atoms and bonds representative of these two hormones.*
FDA Label Image

Figure 1 (Image 02)

Figure 1 (Image 02)
A bar chart depicting mortality rates (number of deaths per 100,000 woman-years) by age group (15-24, 25-34, 35-44, 45+) comparing four groups: ever-users (non-smokers), controls (non-smokers), ever-users (smokers), and controls (smokers). Mortality rates increase significantly in smokers, especially in the 45+ age group. The chart is adapted from P.M. Layde and V. Beral, reference #12.*
FDA Label Image

Isibloom-carton (Isibloom Carton)

Isibloom-carton (Isibloom Carton)
The image shows the flat packaging label for Isibloom, a prescription drug kit labeled by Xiromed, LLC. The package highlights the active ingredients as desogestrel and ethinyl estradiol tablets, USP, with strengths of 0.15 mg and 0.03 mg respectively. The kit contains 3 sets of 28 tablet blister cards, marked with NDC 70700-113-85. The label includes storage instructions, manufacturer details, and warnings about child safety.*
FDA Label Image

Isibloom (Isibloom)

Isibloom (Isibloom)
Isibloom desogestrel and ethinyl estradiol 0.15 mg / 0.03 mg oral tablet kit. The image shows a weekly pill pack designed for a 28-day cycle with four rows labeled Week 1 to Week 4. Each row contains 7 circular tablet compartments labeled with days of the week from Sunday to Saturday. The Week 4 tablets are shaded darker, indicating a different type or inactive pills, while Weeks 1 to 3 tablets are unshaded. The pack includes directional arrows for usage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.